Literature DB >> 1953005

Prediction of blood pressure from plasma renin activity in reflux nephropathy.

H Jardim1, V Shah, J M Savage, T M Barratt, M J Dillon.   

Abstract

As there is a 10% risk of hypertension developing in children with reflux nephropathy and the renin-angiotensin system has been implicated in its aetiology, a long term prospective study has been undertaken to explore the relationship between plasma renin activity (PRA) and blood pressure in such patients. In 1978, of 100 normotensive children with reflux nephropathy 8% were shown to have PRA above normal. Five years later of 85 subjects suitable for analysis 13% had increased PRA and it was shown that PRA and blood pressure SD scores significantly increased. The present study refers to the 10 year follow up in which 95 of the original group were traced but eight of these were unavailable for study and 28 others were excluded from analysis because of extraneous factors that might influence blood pressure or PRA. Results therefore on 59 have been analysed. PRA was above normal in 13/59 (20%) subjects, and PRA and blood pressure SD scores had further increased. The data continue to support the role of the renin-angiotensin system in the observed rise of blood pressure in reflux nephropathy, but individual PRA measurements do not appear so far to predict reliably the onset of hypertension in affected patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953005      PMCID: PMC1793525          DOI: 10.1136/adc.66.10.1213

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Analysis of 100 children with severe and persistent hypertension.

Authors:  D G Gill; B Mendes de Costa; J S Cameron; M C Joseph; C S Ogg; C Chantler
Journal:  Arch Dis Child       Date:  1976-12       Impact factor: 3.791

2.  The long-term follow-up of surgically treated vesicoureteric reflux.

Authors:  D M Wallace; D L Rothwell; D I Williams
Journal:  Br J Urol       Date:  1978-12

3.  Management of children with hypertension from reflux or obstructive nephropathy.

Authors:  V Braren; J C West; R C Boerth; C M Harmon
Journal:  Urology       Date:  1988-09       Impact factor: 2.649

4.  Severe hypertension in childhood.

Authors:  J L Still; D Cottom
Journal:  Arch Dis Child       Date:  1967-02       Impact factor: 3.791

5.  Association between blood pressure and the rate of decline in renal function with age.

Authors:  R D Lindeman; J D Tobin; N W Shock
Journal:  Kidney Int       Date:  1984-12       Impact factor: 10.612

6.  Five year prospective study of plasma renin activity and blood pressure in patients with longstanding reflux nephropathy.

Authors:  J M Savage; C T Koh; V Shah; T M Barratt; M J Dillon
Journal:  Arch Dis Child       Date:  1987-07       Impact factor: 3.791

7.  Measurement of plasma renin activity by semi-micro radioimmunoassay of generated angiotensin I.

Authors:  M J Dillon
Journal:  J Clin Pathol       Date:  1975-08       Impact factor: 3.411

8.  Plasma renin activity, reactivity, concentration and substrate following hypertension during pregnancy. Effect of oral contraceptive agents.

Authors:  T A Kotchen; J M Kotchen; G P Guthrie; C M Cottrill
Journal:  Hypertension       Date:  1979 Jul-Aug       Impact factor: 10.190

9.  Renin and blood-pressure in children with renal scarring and vesicoureteric reflux.

Authors:  J M Savage; M J Dillon; V Shah; T M Barratt; D I Williams
Journal:  Lancet       Date:  1978-08-26       Impact factor: 79.321

  9 in total
  2 in total

1.  Tubular proteinuria in reflux nephropathy: post ureteric re-implantation.

Authors:  C D Goonasekera; V Shah; M J Dillon
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

2.  Reflux nephropathy and hypertension: correlation with the progression of renal damage.

Authors:  Giuliana Lama; Michele Adolfo Tedesco; Luisa Graziano; Elvira Calabrese; Carolina Grassia; Francesco Natale; Giuseppe Pacileo; Pier Francesco Rambaldi; Maria Esposito-Salsano
Journal:  Pediatr Nephrol       Date:  2003-02-26       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.